Literature DB >> 9681614

Multiple carcinoids of the duodenum accompanied by type I familial multiple endocrine neoplasia.

K Yazawa1, T Kuroda, H Watanabe, N Shimozawa, Y Nimura, S Nakata, Y Fujimori, N Koide, S Koike, S Kajikawa, W Adachi, S Kobayashi, K Ishii, J Amano.   

Abstract

A case of multiple carcinoid tumors of the duodenum accompanied by familial multiple endocrine neoplasia is reported. A 46-year-old man with duodenal polyps discovered during a mass screening was followed up for 5 years. In August 1994, a histological examination revealed carcinoid tumors, and he was thus referred to our hospital for surgery. He underwent a parathyroidectomy and cholecystectomy for primary hyperparathyroidism and cholecystolithiasis, respectively. The patient's sister had also undergone a parathyroidectomy and distal pancreatectomy for primary hyperparathyroidism and insulinoma of the pancreas. In addition, his two children were also followed up for hypercalcemia. A serum examination of the patient revealed high levels of somatostatin and pancreatic polypeptide, but normal levels of gastrin and serotonin. In November 1994, a pancreaticoduodenectomy with a D2 lymph node dissection was performed. The macroscopic findings of the resected specimen showed multiple polypoid lesions with delles on the top, measuring 3 to 15 mm in size throughout the duodenum. A microscopic examination revealed the tumor to have infiltrated into the submucosa extensively, and an immunohistochemical analysis also demonstrated the tumor cells to be positive for somatostatin, but not for pancreatic polypeptide. After surgery, the serum level of somatostatin returned to normal but the pancreatic polypeptide remained high. The post-operative course was uneventful, and the patient remains in good health.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681614     DOI: 10.1007/s005950050197

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Carcinoids (Argentaffin-Cell Tumors) and Nerve Hyperplasia of the Appendicular Mucosa.

Authors:  P Masson
Journal:  Am J Pathol       Date:  1928-05       Impact factor: 4.307

2.  Duodenal wall tumors and the Zollinger-Ellison syndrome. Surgical management.

Authors:  J W Hofmann; P S Fox; S D Wilson
Journal:  Arch Surg       Date:  1973-08

3.  Carcinoid-islet cell tumors of the duodenum. Report of twenty-one cases.

Authors:  R F Weichert; L M Roth; E T Krementz; R L Hewitt; T Drapanas
Journal:  Am J Surg       Date:  1971-02       Impact factor: 2.565

4.  Five families with multiple endocrine adenomatosis.

Authors:  N Snyder; M T Scurry; W P Deiss
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

5.  Carcinoid tumors.

Authors:  R C Cheek; H Wilson
Journal:  Curr Probl Surg       Date:  1970-11       Impact factor: 1.909

6.  Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells.

Authors:  J M Polak; A G Pearse; L Grimelius; S R Bloom
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

7.  Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN I syndrome and von Recklinghausen's disease (neurofibromatosis).

Authors:  B Stamm; C E Hedinger; P Saremaslani
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

8.  Primary duodenal carcinoid with malignant carcinoid syndrome: a case report.

Authors:  H Gutman; A A Deutsch; A Leiser; R Reiss
Journal:  Am J Gastroenterol       Date:  1986-02       Impact factor: 10.864

9.  Jejunal endocrine tumor composed of somatostatin and gastrin cells and associated with duodenal ulcer disease.

Authors:  J Alumets; G Ekelund; R Håkanson; O Ljungberg; U Ljungqvist; F Sundler; S Tibblin
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-05-05

10.  Pancreatic somatostatinoma. Clinical features and physiological implications.

Authors:  L I Larsson; M A Hirsch; J J Holst; S Ingemansson; C Kühl; S L Jensen; G Lundqvist; J F Rehfeld; T W Schwartz
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.